Bourg la Reine, France

François Anna

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator François Anna: Pioneering Chimeric Antigen Receptors in Immunology

Introduction: François Anna is a notable inventor based in Bourg la Reine, France, recognized for his contributions to the field of immunology. With a strong focus on developing innovative solutions, he holds a total of three patents reflecting his expertise and commitment to advancing medical science.

Latest Patents: Anna's most recent inventions include his work on chimeric antigen receptors (CAR) specifically designed to target multiple isoforms of human leukocyte antigen (HLA-G). His patents address the immunosuppressive nature of certain HLA-G isoforms, detailing CARs that are unique to both HLA-G β2M-free and β2M-associated forms. These advancements have the potential to greatly enhance therapies in cancer treatment and autoimmune diseases.

Career Highlights: As an integral part of Invectys SA, François Anna has played a crucial role in the development of revolutionary immunological therapies. His commitment and innovative thinking have led to significant advancements that are vital for future research and medical applications.

Collaborations: Throughout his career, Anna has collaborated with esteemed colleagues, including Maria Loustau and Pierre Langlade Demoyen. These partnerships reflect a strong team dynamic that fosters creativity and breakthrough inventions in the field.

Conclusion: François Anna's inventions illustrate not only his ingenuity but also his dedication to improving healthcare solutions through advanced research. His work on chimeric antigen receptors holds promise for the future of immunotherapy, demonstrating the important role inventors play in the evolution of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…